Trust Company of Vermont’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.57K | Hold |
14
| – | – | ﹤0.01% | 935 |
|
2025
Q1 | $3.78K | Hold |
14
| – | – | ﹤0.01% | 887 |
|
2024
Q4 | $3.29K | Hold |
14
| – | – | ﹤0.01% | 907 |
|
2024
Q3 | $3.85K | Buy |
+14
| New | +$3.85K | ﹤0.01% | 878 |
|
2022
Q4 | – | Sell |
-500
| Closed | -$100K | – | 873 |
|
2022
Q3 | $100K | Buy |
+500
| New | +$100K | 0.01% | 384 |
|